Jill Hackell

5.3k total citations · 1 hit paper
29 papers, 3.9k citations indexed

About

Jill Hackell is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Jill Hackell has authored 29 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 18 papers in Microbiology and 5 papers in Infectious Diseases. Recurrent topics in Jill Hackell's work include Pneumonia and Respiratory Infections (26 papers), Bacterial Infections and Vaccines (18 papers) and Respiratory viral infections research (11 papers). Jill Hackell is often cited by papers focused on Pneumonia and Respiratory Infections (26 papers), Bacterial Infections and Vaccines (18 papers) and Respiratory viral infections research (11 papers). Jill Hackell collaborates with scholars based in United States, Germany and South Africa. Jill Hackell's co-authors include Henry R. Shinefield, Steven Black, Paula Ray, Bruce Fireman, George R. Siber, John Hansen, Edwin Lewis, Ih Chang, Robert Kohberger and Dace V. Madore and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

Jill Hackell

29 papers receiving 3.8k citations

Hit Papers

Efficacy, safety and immunogenicity of heptavalent pneumo... 2000 2026 2008 2017 2000 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Hackell United States 20 3.6k 1.8k 437 363 263 29 3.9k
Frank Malinoski United States 23 3.1k 0.8× 1.4k 0.8× 645 1.5× 347 1.0× 507 1.9× 50 3.8k
Dace V. Madore United States 26 3.8k 1.0× 2.2k 1.2× 292 0.7× 288 0.8× 310 1.2× 47 4.3k
Kathryn M. Edwards United States 16 2.5k 0.7× 1.6k 0.9× 288 0.7× 200 0.6× 237 0.9× 22 2.8k
John Hansen United States 24 4.1k 1.1× 1.9k 1.0× 569 1.3× 278 0.8× 388 1.5× 63 4.8k
Lode Schuerman Belgium 34 3.8k 1.1× 2.8k 1.5× 427 1.0× 343 0.9× 232 0.9× 97 4.4k
Aino K. Takala Finland 27 3.4k 0.9× 2.2k 1.2× 365 0.8× 532 1.5× 500 1.9× 59 4.1k
Noga Givon‐Lavi Israel 43 4.6k 1.3× 2.0k 1.1× 596 1.4× 791 2.2× 574 2.2× 149 5.5k
David P. Greenberg United States 35 3.3k 0.9× 1.5k 0.8× 953 2.2× 349 1.0× 262 1.0× 98 4.4k
Janet R. Gilsdorf United States 27 1.5k 0.4× 1.2k 0.6× 315 0.7× 250 0.7× 214 0.8× 96 2.4k
Stephen Lockhart United Kingdom 20 2.0k 0.6× 1.0k 0.6× 932 2.1× 214 0.6× 168 0.6× 52 3.0k

Countries citing papers authored by Jill Hackell

Since Specialization
Citations

This map shows the geographic impact of Jill Hackell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Hackell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Hackell more than expected).

Fields of papers citing papers by Jill Hackell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Hackell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Hackell. The network helps show where Jill Hackell may publish in the future.

Co-authorship network of co-authors of Jill Hackell

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Hackell. A scholar is included among the top collaborators of Jill Hackell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Hackell. Jill Hackell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lode, H., Beate Schmöele-Thoma, William C. Gruber, et al.. (2011). Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1×, 2×, or 4×) in healthy subjects aged 70 years or older. Vaccine. 29(31). 4940–4946. 19 indexed citations
2.
Roux, A de, Beate Schmöele-Thoma, George R. Siber, et al.. (2008). Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory. Clinical Infectious Diseases. 46(7). 1015–1023. 199 indexed citations
3.
O’Brien, Katherine L., Jennifer C. Moïsi, Lawrence H. Moulton, et al.. (2007). Predictors of Pneumococcal Conjugate Vaccine Immunogenicity among Infants and Toddlers in an American Indian PnCRM7 Efficacy Trial. The Journal of Infectious Diseases. 196(1). 104–114. 30 indexed citations
4.
Millar, Eugene V., Katherine L. O’Brien, Melinda A. Bronsdon, et al.. (2007). Anticapsular Serum Antibody Concentration and Protection against Pneumococcal Colonization among Children Vaccinated with 7-Valent Pneumococcal Conjugate Vaccine. Clinical Infectious Diseases. 44(9). 1173–1179. 56 indexed citations
5.
Wright, Peter F., Ruth A. Karron, Shabir A. Madhi, et al.. (2006). The Interferon Antagonist NS2 Protein of Respiratory Syncytial Virus Is an Important Virulence Determinant for Humans. The Journal of Infectious Diseases. 193(4). 573–581. 78 indexed citations
6.
Madhi, Shabir A., Clare Cutland, Yuwei Zhu, et al.. (2005). Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. Vaccine. 24(13). 2432–2439. 27 indexed citations
7.
Karron, Ruth A., Peter F. Wright, Robert B. Belshe, et al.. (2005). Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants. The Journal of Infectious Diseases. 191(7). 1093–1104. 206 indexed citations
8.
Belshe, Robert B., Frances K. Newman, Edwin L. Anderson, et al.. (2004). Evaluation of Combined Live, Attenuated Respiratory Syncytial Virus and Parainfluenza 3 Virus Vaccines in Infants and Young Children. The Journal of Infectious Diseases. 190(12). 2096–2103. 49 indexed citations
9.
O’Brien, Katherine L., Lawrence H. Moulton, Raymond Reid, et al.. (2003). Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. The Lancet. 362(9381). 355–361. 299 indexed citations
10.
Black, Steven, Henry R. Shinefield, Stella Ling, et al.. (2002). Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. The Pediatric Infectious Disease Journal. 21(9). 810–815. 490 indexed citations
11.
Moulton, Lawrence H., Katherine L. O’Brien, Robert Kohberger, et al.. (2001). Design of a Group-Randomized Streptococcus pneumoniae Vaccine Trial. Controlled Clinical Trials. 22(4). 438–452. 48 indexed citations
12.
Black, Steven, Jill Hackell, George R. Siber, et al.. (2000). Efficacy, Safety, and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Children. The American Journal of Managed Care. 6. 3 indexed citations
13.
Black, Steven, Henry R. Shinefield, Bruce Fireman, et al.. (2000). Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. The Pediatric Infectious Disease Journal. 19(3). 187–195. 1817 indexed citations breakdown →
14.
Shinefield, Henry R., Steven Black, Paula Ray, et al.. (1999). Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. The Pediatric Infectious Disease Journal. 18(9). 757–763. 234 indexed citations
15.
Stehr, K, et al.. (1995). Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month–6-year-old German children. European Journal of Pediatrics. 154(3). 209–214. 3 indexed citations
16.
Heininger, Ulrich, James D. Cherry, Peter D. Christenson, et al.. (1994). Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany. Vaccine. 12(1). 81–86. 57 indexed citations
17.
Black, Steven, Henry R. Shinefield, Paula Ray, et al.. (1993). Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Pediatric Infectious Disease Journal. 12(12). 981–985. 19 indexed citations
18.
Glodé, Mary P., Keith S. Reisinger, Mark M. Blatter, et al.. (1992). Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17− to 24-month-old children. The Pediatric Infectious Disease Journal. 11(7). 530–534. 22 indexed citations
20.
Blumberg, Dean A., Candice E. Johnson, Robert S. Daum, et al.. (1991). Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The Journal of Pediatrics. 119(2). 194–204. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026